Strength
262 mg/1
Manufacturer
McKessonNDC
68599474407
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BISMUTH SUBSALICYLATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M008On Market Since
3/1/2022
Price Statistics
The NADAC for BISMUTH 262 MG TABLET CHEW has been published 81 times since Dec 11, 2024, and over the history we have for it it has risen 12.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0831 per EA |
|---|---|
| All-time high | $0.0854 (Dec 10, 2025) |
| All-time low | $0.0739 (Dec 11, 2024) |
| 52-week high | $0.0854 |
| 52-week low | $0.0807 |
| Median price | $0.0826 |
| Average price | $0.0817 |
| Largest weekly change | +5.5% (Feb 19, 2025) |
| Weeks tracked | 81 |
| Tracking since | Dec 11, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the bismuth subsalicylate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BISMUTH 262 MG TABLET CHEW?
The current National Average Drug Acquisition Cost (NADAC) for BISMUTH 262 MG TABLET CHEW, manufactured by McKesson, is $0.0831 per EA (NDC 68599474407), effective Jun 24, 2026.
How has the price of BISMUTH 262 MG TABLET CHEW changed over time?
Over the history we have for it, the NADAC for BISMUTH 262 MG TABLET CHEW has risen 12.5%. It has been tracked across 81 weekly CMS publications since Dec 11, 2024.
What are the highest and lowest recorded NADAC prices for BISMUTH 262 MG TABLET CHEW?
Since Dec 11, 2024, the NADAC for BISMUTH 262 MG TABLET CHEW has ranged from a low of $0.0739 (Dec 11, 2024) to a high of $0.0854 (Dec 10, 2025), with a median of $0.0826 per EA.
Are there cheaper alternatives to BISMUTH 262 MG TABLET CHEW?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BISMUTH 262 MG TABLET CHEW, so no direct lower-cost alternative is listed.
Who manufactures BISMUTH 262 MG TABLET CHEW?
BISMUTH 262 MG TABLET CHEW (NDC 68599474407) is labeled by McKesson, and CMS classifies it as a generic product.
Related Drugs
Same classification